BRIDGEWATER, N.J., May 25, 2021 /PRNewswire/ -- Insmed Incorporated
Inc. (Nasdaq: INSM), a global biopharmaceutical company on a
mission to transform the lives of patients with serious and rare
diseases, today announced that management will present at the
following virtual investor events:
- The Jefferies Virtual Healthcare Conference on June 1, 2021 at 9:00 a.m.
ET in a corporate presentation
- The Goldman Sachs 42nd Annual Global Healthcare
Conference on June 9, 2021 at
2:10 p.m. ET in a fireside chat
Each presentation will be webcast live and can be accessed by
visiting the investor relations section of the Company's website at
www.insmed.com. Each webcast will be archived for a period of 30
days following the conclusion of each live event.
About Insmed
Insmed Incorporated is a global
biopharmaceutical company on a mission to transform the lives of
patients with serious and rare diseases. Insmed's first commercial
product is a first-in-disease therapy approved in the United States, Europe, and Japan to treat a chronic, debilitating lung
disease. The Company is also progressing a robust pipeline of
investigational therapies targeting areas of serious unmet need,
including neutrophil-mediated inflammatory diseases and rare
pulmonary disorders. Insmed is headquartered in Bridgewater, New Jersey, with a growing
footprint across Europe and in
Japan. For more information, visit
www.insmed.com.
Contact:
Investors:
Eleanor Barisser
Associate Director, Investor Relations
Insmed
(718) 594-5332
eleanor.barisser@insmed.com
Media:
Mandy Fahey
Senior Director, Corporate Communications
Insmed
(732) 718-3621
amanda.fahey@insmed.com
View original content to download
multimedia:http://www.prnewswire.com/news-releases/insmed-to-present-at-two-june-conferences-301298212.html
SOURCE Insmed Incorporated